OSL collaborates with Singleton Hospital – Artificial Intelligence in Radiotherapy
11th June 2021
Oncology Systems Limited (OSL), is pleased to be working with Singleton Hospital, Swansea, in collaboration to investigate the positive benefits of introducing “ART-Plan™” artificial intelligence into their radiotherapy planning workflow.
“With the anticipated wave of patients heading into the system due to a hold-back from Covid we are looking to mobilise technology to aid us in keeping ahead of this curve by saving planners and clinicians countless hours sat in front of computer screens identifying critical avoidance anatomy used in formulating our treatment plans”, commented Adam Selby, Clinical Scientist at the Medical Physics department in Singleton.
“Harnessing AI will, we envisage, bring us greater consistency, enhanced accuracy, and unmatched speed in performing what is currently laborious, time-consuming procedures that have eluded us using older technologies. This will enable us to deliver timely treatments for our patients without incurring a penalty of late starting due to a resource issue in planning, we want to remove any potential bottlenecks in this time-critical process” says Adam.
“We have done our homework and found that our partners, TheraPanacea, offer a game-changing technology for auto-contouring in RT planning. We have investigated the results derived from their AI algorithms using OSL’s world-class contour analysis software ImSimQA™, and find their ability to contour over 80 structures with a consistent, accurate result, very impressive indeed. Combine this with the capability to plugin to our planning platform ProSoma® enables a truly cohesive workflow allowing our users to work remotely 24 x 7 to ensure timely treatments for their patients”, adds Stuart Southgate, Commercial Director at OSL.
To learn more about how AI can benefit your department please contact sales@osl.uk.com
